Nolwenn Tessier
Overview
Explore the profile of Nolwenn Tessier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vachon L, Jean G, Milasan A, Babran S, Lacroix E, Guadarrama Bello D, et al.
Commun Biol
. 2024 Aug;
7(1):975.
PMID: 39128945
Lymphatic vessels are essential for preventing the accumulation of harmful components within peripheral tissues, including the artery wall. Various endogenous mechanisms maintain adequate lymphatic function throughout life, with platelets being...
2.
Burelle C, Clapatiuc V, Deschenes S, Cuillerier A, De Loof M, Higgins M, et al.
Commun Biol
. 2024 Mar;
7(1):356.
PMID: 38519536
Lean patients with NAFLD may develop cardiac complications independently of pre-existent metabolic disruptions and comorbidities. To address the underlying mechanisms independent of the development of obesity, we used a murine...
3.
Tessier N, Ducrozet M, Dia M, Badawi S, Chouabe C, Crola Da Silva C, et al.
Cells
. 2023 Sep;
12(18).
PMID: 37759544
The Ca release in microdomains formed by intercompartmental contacts, such as mitochondria-associated endoplasmic reticulum membranes (MAMs), encodes a signal that contributes to Ca homeostasis and cell fate control. However, the...
4.
Amri N, Tessier N, Begin R, Vachon L, Begin P, Bazin R, et al.
Cells
. 2022 Oct;
11(19).
PMID: 36231083
Despite the advancement of vaccination and therapies currently available, deaths due to the coronavirus disease 2019 (COVID-19) are still heavily documented. Severely infected individuals experience a generalized inflammatory storm, caused...
5.
Raynard C, Tessier N, Huna A, Warnier M, Flaman J, Van Coppenolle F, et al.
Int J Mol Sci
. 2022 Aug;
23(16).
PMID: 36012633
In response to many stresses, such as oncogene activation or DNA damage, cells can enter cellular senescence, a state of proliferation arrest accompanied by a senescence-associated secretory phenotype (SASP). Cellular...
6.
Raynard C, Ma X, Huna A, Tessier N, Massemin A, Zhu K, et al.
Aging Cell
. 2022 Jun;
21(7):e13632.
PMID: 35653631
Cellular senescence is characterized by a stable proliferation arrest in response to stresses and the acquisition of a senescence-associated secretory phenotype, called SASP, composed of numerous factors including pro-inflammatory molecules,...
7.
Boucheniata C, Tessier N, Martel C
Front Cardiovasc Med
. 2022 May;
9:915262.
PMID: 35600471
No abstract available.
8.
Amri N, Begin R, Tessier N, Vachon L, Villeneuve L, Begin P, et al.
Pharmaceuticals (Basel)
. 2022 Mar;
15(3).
PMID: 35337162
Convalescent plasma therapy (CPT) has gained significant attention since the onset of the coronavirus disease 2019 (COVID-19) pandemic. However, clinical trials designed to study the efficacy of CPT based on...
9.
Vachon L, Smaani A, Tessier N, Jean G, Demers A, Milasan A, et al.
Theranostics
. 2022 Feb;
12(3):1440-1458.
PMID: 35154499
Impairment in lymphatic transport is associated with the onset and progression of atherosclerosis in animal models. The downregulation of low-density-lipoprotein receptor (LDLR) expression, rather than increased circulating cholesterol level ,...
10.
Tessier N, Moawad F, Amri N, Brambilla D, Martel C
Pharmaceutics
. 2021 Aug;
13(8).
PMID: 34452161
While oral agents have been the gold standard for cardiovascular disease therapy, the new generation of treatments is switching to other administration options that offer reduced dosing frequency and more...